Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

671 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study.
Narita C, Urabe F, Fukuokaya W, Iwatani K, Imai Y, Yasue K, Mori K, Aikawa K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Yamada Y, Yuen SKK, Teoh JY, Shimomura T, Yamada H, Furuta A, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Narita C, et al. Among authors: tsuzuki s. Clin Genitourin Cancer. 2024 Mar 21:102082. doi: 10.1016/j.clgc.2024.102082. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38641443
[CLINICAL CHARACTERISTICS OF T1 HIGH GRADE BLADDER CANCER].
Tsuzuki S, Miki J, Moritake J, Kimura S, Shimomura T, Kimura T, Kishimoto K, Egawa S. Tsuzuki S, et al. Nihon Hinyokika Gakkai Zasshi. 2015 Apr;106(2):71-8. doi: 10.5980/jpnjurol.106.71. Nihon Hinyokika Gakkai Zasshi. 2015. PMID: 26415356 Japanese.
[OUTCOMES AFTER SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA].
Moritake J, Miki J, Tsuzuki S, Hata K, Shimomura T, Kimura T, Furuta A, Furuta N, Egawa S. Moritake J, et al. Among authors: tsuzuki s. Nihon Hinyokika Gakkai Zasshi. 2016;107(2):79-86. doi: 10.5980/jpnjurol.107.79. Nihon Hinyokika Gakkai Zasshi. 2016. PMID: 28442674 Free article. Japanese.
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab.
Fukuokaya W, Kimura T, Yanagisawa T, Kimura S, Tsuzuki S, Koike Y, Iwamoto Y, Enei Y, Tanaka M, Urabe F, Onuma H, Honda M, Miki J, Oyama Y, Abe H, Egawa S. Fukuokaya W, et al. Among authors: tsuzuki s. BJU Int. 2021 Jan;127(1):90-95. doi: 10.1111/bju.15176. Epub 2020 Aug 6. BJU Int. 2021. PMID: 32662189
671 results